“…Within the last few years, A. caninum genetic markers for benzimidazole drug-resistance became available ( Furtado et al, 2014 , Schwenkenbecher and Kaplan, 2009 , Venkatesan et al, 2023 ) and can be used to evaluate the distribution of fenbendazole resistance in A. caninum in USA dogs ( Jimenez Castro et al, 2021 , Leutenegger et al, 2023 ). Venkatesan et al (2023) and Leutenegger et al (2023) demonstrated it is no longer just a “Greyhound problem,” as the fenbendazole resistance genetic marker in A. caninum is now widely distributed in USA pet dogs. In the USA, there are at least two MADR A. caninum published case reports, characterized through both in vivo and in vitro studies ( Jimenez Castro et al, 2019 ; Kitchen et al, 2019 ; Jimenez Castro et al, 2020b ).…”